Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients.
Chebani R, Lombart F, Chaby G, Dadban A, Debarbieux S, Viguier MA, Ingen-Housz-Oro S, Pham-Ledard A, Bedane CR, Picard-Dahan C, Berthin C, Dereure O, Konstantinou MP, Castel M, Jouen F, Joly P, Seta V, Duvert-Lehembre S, Le Roux C, Quereux G, Sassolas B, Brenaut E, Sin C, Richard MA, Bérard F, Giusti D, Belmondo T, Gille T, Caux F, Prost-Squarcioni C, Grootenboer-Mignot S, Alexandre M; French Study Group on Autoimmune Bullous Diseases. Chebani R, et al. Among authors: prost squarcioni c. Br J Dermatol. 2024 Jan 23;190(2):258-265. doi: 10.1093/bjd/ljad369. Br J Dermatol. 2024. PMID: 37792727
[Cicatricial pemphigoid: treatment with mycophenolate mofetil].
Ingen-Housz-Oro S, Prost-Squarcioni C, Pascal F, Doan S, Brette MD, Bachelez H, Dubertret L. Ingen-Housz-Oro S, et al. Ann Dermatol Venereol. 2005 Jan;132(1):13-6. doi: 10.1016/s0151-9638(05)79188-2. Ann Dermatol Venereol. 2005. PMID: 15746600 Clinical Trial. French.
[Role of the nurse in care of bullous pemphigoid].
Le Roux-Villet C, Prost-Squarcioni C, Oro S, Roujeau JC, Joly P, Lemercier C. Le Roux-Villet C, et al. Rev Infirm. 2010 May;(160):38-40. Rev Infirm. 2010. PMID: 20461987 French. No abstract available.
[Epidermolysis bullosa acquisita. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].
Prost-Squarcioni C, Ingen-Housz-Oro S, Joly P, Bernard P, Bedane C; Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie. Prost-Squarcioni C, et al. Ann Dermatol Venereol. 2011 Mar;138(3):274-9. doi: 10.1016/j.annder.2011.01.013. Epub 2011 Feb 18. Ann Dermatol Venereol. 2011. PMID: 21397160 French. No abstract available.
Rituximab for patients with refractory mucous membrane pemphigoid.
Le Roux-Villet C, Prost-Squarcioni C, Alexandre M, Caux F, Pascal F, Doan S, Brette MD, Soued I, Gabison É, Aucouturier F, Letestu R, Laroche L, Bachelez H. Le Roux-Villet C, et al. Arch Dermatol. 2011 Jul;147(7):843-9. doi: 10.1001/archdermatol.2011.54. Epub 2011 Mar 21. Arch Dermatol. 2011. PMID: 21422323
Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita.
Zumelzu C, Le Roux-Villet C, Loiseau P, Busson M, Heller M, Aucouturier F, Pendaries V, Lièvre N, Pascal F, Brette MD, Doan S, Charron D, Caux F, Laroche L, Petit A, Prost-Squarcioni C. Zumelzu C, et al. J Invest Dermatol. 2011 Dec;131(12):2386-93. doi: 10.1038/jid.2011.231. Epub 2011 Aug 11. J Invest Dermatol. 2011. PMID: 21833018 Free article.
66 results